'No Second China': EU Firms Face Coronavirus Fallout
The general economic and business impact on European firms from the coronavirus in China is widespread and severe, and companies must consider diversifying, warns an influential European trade group in a just-released business survey. But it concedes there are no China alternatives.
You may also be interested in...
More countries are joining the US to put national security interests over globalization, moving the production of medicines, medical supplies and protective equipment closer to home. The calls to repatriate manufacturing and reduce reliance on China will profoundly change how health products are supplied worldwide in the post-coronavirus era.
As global buyers rush to order protective face masks, testing kits and ventilators from China, the world's largest medical supplies producer, some manufacturers are refusing to take the orders.
Indian pharmaceutical companies will soon be asked to seek a no objection certificate for the export of 12 APIs and their formulations, as the country deals with Chinese raw material supply disruptions on the back of the coronavirus crisis. However, the move is not expected to impact the export quantum for now.